Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the generic medication Carmustine Obvius (carmustine) for the treatment of non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, and brain tumors. The CHMP is EMA’s committee responsible ... Read more